The ClearPlan Easy TM Fertility Monitor* predicts the times of high potential fertility, i.e. the times when sexual intercourse is most likely to result in conception. The test procedure identifies the times of specified changes in the concentration of urinary hormone metabolites during each ovarian cycle. The results are displayed in terms of prior knowledge about the time-specific probabilities of conception. This paper contains a summary of the scientific background that led to the development of the ClearPlan Easy TM Fertility Monitor.
Introduction
For some time there has been a need to develop accurate, easy-to-use self-tests to predict the most potentially fertile times in women who want to plan a pregnancy. The aim of this paper is to highlight the biological concepts and principles that led to the production of the ClearPlan Easy™ Fertility Monitor (developed by Unipath Ltd, UK) for this purpose. The test procedure involves identifying the times of defined changes in the daily concentration of an estrogen metabolite and gonadotrophic luteinizing hormone (LH) in urine. Prior knowledge about the time-specific probability of conception relative to the estimated time of ovulation is used to interpret the test results in terms of potential fertility.
Women who want to become pregnant need to know in advance when the most fertile days will occur after their last menses. We have termed this period 'the window of opportunity'. Women who want to avoid a pregnancy need to know the start and end of each potentially fertile period and about 'the risk of pregnancy' from acts of intercourse either within or outside the derived limits. A personal contraceptive system (PERSONA™) † has been developed (by Unipath Ltd, UK) to identify the times of change in the levels of urinary hormone metabolites. 1 The system involves the use of immunochemical urine test sticks, and an electronic reader and microprocessor.
The ClearPlan Easy™ Fertility Monitor is based on the same technology for identifying potential fertility. There are, however, important differences between the two monitors in the frequency of sampling Potential Fertility -Defining the Window of Opportunity and in the decision-making algorithms that are used -depending on whether the aim is to avoid, or achieve, a pregnancy. The intention, for contraceptive purposes, is to minimize the risk of pregnancy and emphasis is placed on ensuring that the infertile days are accurately located over a long period of time, with little chance of false-positive signals. Conversely, the intention for achieving pregnancy is to maximize the chances of conceiving as soon as possible by predicting the most potentially fertile days for sexual intercourse.
Background
Physiological, biochemical and statistical evidence for cyclical periods of potential fertility in women has been reviewed. 2 -4 The scientific principles that underlie the concept of a 'window of opportunity' can be summarized as follows. A 'window of opportunity' occurs only when ovulation leads to the presence of a viable oocyte in the female reproductive tract. Ovulation and the ability of the female and male gametes to meet and form a conceptus, and the ability of the latter to implant in the endometrium, are dependent upon the production of female hormones -primarily estradiol and LH. 2 Defined changes in the production of estradiol and LH (e.g. from the levels of the hormones in serum 5, 6 or their metabolites in urine 3 ) can be used to predict ovulation and, in relation to calculated conception rates on specific days, 4 the most potentially fertile time.
The 'window of opportunity' becomes the fertile period if pregnancy occurs and day 1 of menses is used as the reference point for serial testing. The dominant ovarian follicle starts to secrete increasing amounts of estradiol from around days 7 -18 in women with regular menstrual cycles. 7 Only a proportion of apparently ovulatory cycles result in the development of a viable conceptus after appropriately timed intercourse. For example, Wilcox et al. 14 concluded that daily acts of intercourse during the potentially fertile period failed to produce a viable pregnancy in approximately 66% of presumed ovulatory cycles according to hormonal indices. Accordingly, 'the window of opportunity' can only be described in statistical terms due to uncertainty about the time or occurrence of ovulation, the variable life-spans of the ovum and sperm in the female reproductive tract, 4 and the contribution of other factors to the potential fertility of an individual couple.
Tests of potential fertility
Between the 1950s and the 1990s, significant progress was made in developing technologies to improve the ability of women to identify the probable time of ovulation 15 and to locate the outer limits 4A JM Spieler, WP Collins Potential fertility -defining the window of opportunity of the fertile period. In particular, the approaches moved from the very imprecise technique of calendar rhythm, and the limited use of basal body temperature (BBT) measurements, to monitoring changes in the quantity and quality of cervical mucus; from relatively unsophisticated bioassays and colorimetric methods to immunoassays for the measurement of reproductive hormones; from complicated laboratory procedures to simple do-it-yourself methods for the measurement of human chorionic gonadotrophin (hCG) and LH; and from the first use of transabdominal ultrasonography in the late 1970s and early 1980s to observe follicular development and rupture to transvaginal color Doppler imaging. The latter also permits the study of blood velocity changes in the follicle, corpus luteum, uterine arteries and endometrium. 16 Research into the measurement of hormones in different body fluids resulted in the recognition that salivary progesterone could be used as a good marker of ovulation and luteal function and that measurement of the urinary metabolites of estradiol, LH and progesterone could be used as a proxy for plasma or serum hormone levels and patterns of secretion. 17 The development of home assay kits for urinary hCG to diagnose or confirm pregnancy, and the urinary LH tests to assist in identifying the days of maximum fertility, made the term 'kitchen chemistry' a reality.
Role of the World Health Organization (WHO)
In 1973 By the end of the 1970s, the Task Force redefined its mandate to include methods for the prediction of ovulation and, subsequently, it expanded its brief to become the Task Force on Methods for the Determination of the Fertile Period. Author JM Spieler was the Manager of the Task Force from its inception to 1983, and author WP Collins was a member of the Steering Committee of the Task Force and the primary consultant for its work on ovulation prediction and detection.
In order to empower women to determine the times of potential fertility using hormonal measurements, the Task Force embarked on a worldwide program to seek and develop simple immunochemical tests that could be used in the home to predict or detect ovulation. Another early objective was to determine the temporal relationships between ovulation and defined changes in the level of circulating hormones. 5, 6 The principal findings are summarized in Table 1. A decision was then made that the measurement of estradiol or a primary metabolite would offer the best opportunity to predict ovulation early enough to account for the fertilizing life-span of sperm in the female reproductive tract. Since it was also decided that the measurement of plasma or serum hormones was impractical for home use, it was necessary to identify which of the urinary metabolites of 17β-estradiol could be used to form the basis of a home test.
Urinary hormone metabolites
The measurement of urinary, rather than plasma/serum, hormones was chosen because the procedure is safe and makes frequent 5A JM Spieler, WP Collins Potential fertility -defining the window of opportunity JM Spieler, WP Collins Potential fertility -defining the window of opportunity sampling easier; it is non-invasive and practical, and it is less stressful for the woman. The principal immediate metabolites of 17β-estradiol are estradiol-17β-glucuronide and estradiol-3-glucuronide (Fig. 1) . Estradiol is also readily converted to estrone, which is metabolized to estrone-3-glucuronide (E3G). The metabolic process tends to favor the formation of E3G, therefore the reagents used to measure this and other urinary metabolites of estradiol 18 (and of progesterone) were incorporated into radioimmunoassays.
The WHO Task Force supported many international and multicenter studies to evaluate the excretion patterns of each metabolite and the relationship of defined concentration changes to the time of presumed ovulation (using the LH peak or follicle rupture as reference points). Studies also aimed to determine the most feasible approaches to developing simple methods of measurement. 19 -21 The end result was the selection of E3G as the most appropriate metabolite for developing simple methods to 6A 
FIGURE 1: Principal interconversions of estradiol and related phenolic estrogens
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Estrone-3-glucuronide Estradiol-3-glucuronide JM Spieler, WP Collins Potential fertility -defining the window of opportunity predict ovulation and the start and end of potential fertility; the urinary concentration of E3G is relatively high compared with other estrogen metabolites and the molecular structure lends itself to the production of reagents for immunoassay. The measurement of urinary LH was selected as the best hormonal method for predicting imminent ovulation.
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The first one-step immunochemical test for detecting an increased level of urinary hCG was marketed by Unipath in 1988, and a related test for detecting changes in urinary LH (ClearPlan™ One Step)* was released in 1989. The ClearPlan Easy™ Fertility Monitor (and PERSONA™), as Step is a trademark owned by or licensed to the Unilever group of companies.
JM Spieler, WP Collins
Potential fertility -defining the window of opportunity urinary E3G was reported throughout 10 control menstrual cycles in a study of infertile women. 23 Either index (serum hormone or urinary metabolite) could be used in an appropriate algorithm to predict the LH peak day and, hence, the presumed day of ovulation. Depending on where the threshold level (e.g. the defined rise above a baseline value) is selected, it is possible to obtain more, or fewer, days of warning of the LH surge or rise. The results of a large study of 445 women with regular menstrual cycles showed that the median time for a defined rise in the concentration of urinary E3G occurred on day 9 of the menstrual cycle. 7 The time of the defined rise in urinary E3G occurred approximately 118 h before the urinary LH peak (Table 1) . 8
Urinary E3G and cervical mucus
The relationship between the concentration of urinary E3G and the presence and type of cervical mucus within the vagina has been studied over 58 cycles from 10 women. 8 The first day of mucus was defined as the day on which there was a sensation of dampness (i.e. no longer dry) or the first visual appearance of mucus. The first day of fertiletype mucus was the first day that a sensation of wetness or a slippery feeling was recorded (with or without the appearance of any kind of mucus) or the appearance of clear, stretchy mucus. The day of peak mucus was the last day of the fertile-type mucus, which could only be determined retrospectively.
The cumulative frequency (%) of days on which the signals for first mucus and first fertile-type mucus occurred relative to the day of the urinary LH peak is shown in Fig. 3. An algorithm, based on cumulative (CUSUM) analysis, was developed to give a cumulative frequency curve for the day of defined rise in the concentration of urinary E3G, which fell between the curves for first mucus and first fertile-type mucus. 8 The algorithm could be modified to produce a curve to the left or right to obtain more or fewer days warning of ovulation, respectively -depending on the clinical objective. The mean time for the day of peak mucus occurred on the same day as the peak of urinary LH.
Urinary LH and ovulation
Peak LH in daily urine samples was used as an index of ovulation to study the pattern of E3G excretion during regular menstrual cycles. 19 The use of these hormonal indices to validate the value of transabdominal ultrasonography for the detection of follicle rupture (presumed ovulation) was reported in 1980. 24 More recently, a positive ClearPlan™ One Step test result for urinary LH has been used as a reference point to study detailed changes in ovarian and uterine structure and blood flow using transvaginal ultrasonography with color Doppler imaging. 25, 26 These studies added further data to support the hypothesis that a good blood supply and complementary structural changes in the follicle and endometrium are associated with high potential fertility.
The temporal relationships between a positive ClearPlan™ One Step test result and follicle rupture, using data from 6-hourly or 24-hourly sampling, have also been reported, 16 and the results are shown in Table 1 . It is reassuring that the median and range of values compare favorably with those obtained from the WHO study, which involved defined changes in the level of plasma LH and histological evidence of ovulation. 5 The range of values from the urinary LH rise to ovulation with 24 h sampling (8 -24 h) suggests that the use of JM Spieler, WP Collins Potential fertility -defining the window of opportunity 9A the LH index alone for high potential fertility may occur too late to be of practical value for some women.
Probability of conception
The definitive method for defining the time of potential fertility should determine the probability of conception on different days around the estimated time of ovulation. hormonal data from a subgroup of 625 ovarian cycles from 217 women who were planning to become pregnant. 14 The time of ovulation was estimated from the ratio of urinary E3G to pregnanediol-3-glucuronide (PG) in daily early-morning urine samples. There were 129 live births. A single act of intercourse was recorded for 129 cycles (21% of total) during a 6-day potentially fertile period. The probability of conception from single acts of intercourse on specific days, and from a statistical model, relative to the estimated day of ovulation is summarized in Fig. 4 . The probability of pregnancy from single acts of intercourse ranged from 0.08 (5 days before ovulation) to 0.36 (on day of ovulation). The corresponding probabilities from the statistical model and data from all 625 cycles Potential fertility -defining the window of opportunity 
Time of most potential fertility
A systematic attempt to investigate the effect of changing variables in a statistical model, to identify the time of maximum conception probability from the concentration of E3G in daily early-morning urine samples, has been reported. 31 Data from 118 prospective cycles (12 conceptional) were analysed. The aim was to obtain a prospective signal of the most potentially fertile days near the time of urinary E3G peak. The best algorithm gave a successful signal in 75% of cycles, and the 10A JM Spieler, WP Collins Potential fertility -defining the window of opportunity mean time interval to the urinary LH peak was -0.87 days. The corresponding values using the time of maximum follicular diameter as the reference point for ovulation in 38 cycles were 82% and -0.42 days. The success rate for the 12 conception cycles was 92%.
These data, together with the studies with ClearPlan™ One
Step 25, 26 and the life-span of the ovum, 29 suggest that a test based upon the measurement of urinary E3G and LH could be devised to locate the overall time of most potential fertility during an ovarian cycle. Signals from the measurement of both hormone metabolites should enable intercourse to be timed so that sperm have access to the ovum whether their passage is rapid or follows storage in the cervical crypts or in the distal (uterine intra-mural) isthmus of the fallopian tube. 32 Furthermore, an interim report from a European multicenter study of conception probabilities suggests that the number of days with the most fertile-type mucus has a major impact on potential fertility, 33 and we believe this finding should be reflected by the changing levels of urinary E3G and LH and the time interval from the LH signal to the demise of the ovum.
Conclusions
Data accumulated over the past 50 years show there is a good statistical correlation between a number of home, laboratorybased and clinical tests of potential fertility during each ovarian cycle and actual fertility. Moreover, defined changes in BBT or urinary hormone ratios have been related to day-specific conception rates. This information and technical developments in assay format and microprocessing have stimulated the development of the new ClearPlan Easy™ Fertility Monitor, which involves the concurrent measurement of E3G and LH in daily samples of early-morning urine. There is still a need, however, to study the potential effect of many factors such as diet, drugs and strenuous exercise on the efficacy of the test (and even the ability to conceive). The ClearPlan Easy™ Fertility Monitor is, nevertheless, likely to be a valuable aid to many couples who wish to locate the 'window of opportunity' and conceive as quickly as possible. The test is easy to perform and the results may indicate the need to change lifestyles. It is interesting that preliminary data show that subfertile women significantly improve their chances of conception when a method of stress reduction, or the use of a support group, is included in their treatment. 34 We anticipate that the use of the ClearPlan Easy™ Fertility Monitor by subfertile women should improve pregnancy rates and facilitate research into factors affecting potential fertility and conception.
